Metharbital was patented in 1905 by Emil Fischer working for Merck.[2] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy.[3][4] It has similar properties to phenobarbital.
Clinical data | |
---|---|
Other names | Endiemal, metharbitone, methobarbitone[1] |
Routes of administration | By mouth (tablets) |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.011 |
Chemical and physical data | |
Formula | C9H14N2O3 |
Molar mass | 198.222 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |
Metharbital can be synthesized from 2,2-diethylmalonic acid and O-methylisourea.[5][6][2]